EUVIMEDEUVIMED entdecken
Leserbrief

Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension

Hooman D Poor, Jimmy Zhang, Simone Hannah-Clark, Shyla Saini, Elliot Eisenberg, Jing Wang, Alison G Lee, Gregory Serrao, Helena Schotland, Linda Rogers, Benjamin M Smith, Mary Beth Beasley und 4 weitere

European Respiratory Journal · 2026-05 · 67 (5) · 2502731

DOI: 10.1183/13993003.02731-2025 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 19.03.2026. Verfasst von Hooman D Poor und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA hooman.poor@mountsinai.org. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Institutes of Health, American Heart Association.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extract Patients with pulmonary arterial hypertension (PAH) have a high prevalence of small airways disease (SAD) [1]. The mechanisms and implications of SAD in PAH are not entirely clear. Precapillary pulmonary hypertension (PH) occurs in cardiopulmonary conditions other than PAH, such as left heart failure, interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD), and sarcoidosis. SAD is highly prevalent in these conditions [2–5]. Sotatercept, an activin-signaling inhibitor, is an effective therapy approved for PAH [6]. We recently reported improved lung function, particularly indices of small airway function, following sotatercept treatment in patients with sarcoidosis-associated PH [7]. The aim of this present study was to assess changes in lung function in a broader group of patients with significant precapillary PH treated with sotatercept. We hypothesized that markers of SAD and hyperinflation would improve in patients with precapillary PH after treatment with sotatercept.

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA hooman.poor@mountsinai.org.
  • Mount Sinai Respiratory Institute, Mount Sinai Health System, New York, NY, USA.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Division of Pulmonary, White Plains Hospital, White Plains, NY, USA.
  • Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Medicine, McGill University and McGill University Health Center Research Institute, Montreal, QC, Canada.

Förderung

  • National Institutes of Health
  • American Heart Association

Zitieren

APA

Poor, H. D., Zhang, J., Hannah-Clark, S., Saini, S., Eisenberg, E., Wang, J., Lee, A. G., Serrao, G., Schotland, H., Rogers, L., Smith, B. M., Beasley, M. B., Li, M., Powell, C. A., Ventetuolo, C. E., & Padilla, M. (2026). Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension. European Respiratory Journal, 67(5), 2502731. https://doi.org/10.1183/13993003.02731-2025

Vancouver

Poor HD, Zhang J, Hannah-Clark S, Saini S, Eisenberg E, Wang J, et al. Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension. European Respiratory Journal. 2026;67(5):2502731. doi:10.1183/13993003.02731-2025

BibTeX
@article{Poor2026,
  author = {Poor, Hooman D and Zhang, Jimmy and Hannah-Clark, Simone and Saini, Shyla and Eisenberg, Elliot and Wang, Jing and Lee, Alison G and Serrao, Gregory and Schotland, Helena and Rogers, Linda and Smith, Benjamin M and Beasley, Mary Beth and Li, Michelle and Powell, Charles A and Ventetuolo, Corey E and Padilla, Maria},
  title = {Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {67},
  number = {5},
  pages = {2502731},
  doi = {10.1183/13993003.02731-2025}
}
Kostenlos starten →